MS
ENFN

Marc Stad’s Enfusion, Inc. ENFN Stock Holding History

Marc Stad’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,218,452
Closed -$44.3M – 29
2023
Q1 		$44.3M Sell
4,218,452
-1,809,434
-30% -$19.9M 1.05% 20
2022
Q4 		$58.3M Sell
6,027,886
-462,114
-7% -$5.2M 1.81% 17
2022
Q3 		$80.1M Hold
6,490,000
– – 2.11% 16
2022
Q2 		$66.3M Hold
6,490,000
– – 1.7% 18
2022
Q1 		$82.6M Buy
6,490,000
+67,779
+1% +$1.04M 1.05% 24
2021
Q4 		$134M Buy
+6,422,221
New +$130M 1.54% 18

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $514M AUM 4.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $213M AUM 42.16% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Marc Stad's ENFN Position: Q2 2023 in Review

Marc Stad sold out of Enfusion, Inc. (ENFN) in Q2 2023, closing a stake of 4,218,452 shares — an estimated $44.3M sold.

Marc Stad first reported a position in ENFN in Q4 2021 and held it in 6 quarters. The position peaked at $134M in Q4 2021. 83 funds tracked by Wall St. Rank hold ENFN as of Q2 2023.

  • Marc Stad reported no remaining Enfusion, Inc. position as of Q2 2023 after selling out during the quarter.
  • Marc Stad sold 4,218,452 Enfusion, Inc. shares in Q2 2023, an estimated $44.3M.
  • Marc Stad first reported a position in Enfusion, Inc. in Q4 2021 and held it in 6 quarters.
  • Marc Stad's Enfusion, Inc. position peaked at $134M in Q4 2021.
  • 83 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2023.

Based on Dragoneer Investment Group's 13F filing for Q2 2023, filed 14 Aug 2023.